efanesoctocog alfa
ItalyDrugs containing this active substance
-
It is used for the treatment and prevention of bleeding episodes in patients with hemophilia A, a hereditary disorder caused by the deficiency or dysfunction of factor VIII.
Form: solution for injection, powder and solvent
Active substance Dosage efanesoctocog alfa - ATC: B02BD02
Manufacturer: SWEDISH ORPHAN BIOVITRUM AB (PUBL)